12/18/2024
10:06 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024
1:42 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2024
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
12/12/2024
4:08 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/04/2024
7:32 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024
3:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/24/2024
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
|
11/22/2024
3:30 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
10/31/2024
3:59 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024
8:45 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024
7:35 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2024
7:30 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024
8:35 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/09/2024
8:13 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/06/2024
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
10/01/2024
5:00 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
09/30/2024
3:53 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024
8:25 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
5:10 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024
5:10 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024
4:00 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/28/2024
6:05 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024
7:00 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024
8:00 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024
8:24 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/09/2024
8:29 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2024
8:11 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024
7:05 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024
7:20 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
06/27/2024
7:00 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024
7:16 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
06/24/2024
8:20 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024
3:42 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024
4:24 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
06/17/2024
4:25 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
06/17/2024
4:22 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
6:14 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
05/20/2024
3:16 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form F-1/A | |
05/20/2024
8:02 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
8:02 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
05/07/2024
9:21 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024
3:01 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
04/12/2024
3:30 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024
3:30 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B5 | |
04/10/2024
8:00 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
7:32 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
04/08/2024
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
04/05/2024
8:28 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
4:10 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
04/04/2024
3:31 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/04/2024
3:37 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
02/22/2024
7:25 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/13/2024
12:20 PM | Gordon Ariel (Filed by)
NeuroSense Therapeutics (Subject)
NeuroSense Therapeutics Ltd. (Subject)
| Form SC 13G/A | |
02/13/2024
9:14 AM | Ben-Noon Alon (Filed by)
NeuroSense Therapeutics (Subject)
NeuroSense Therapeutics Ltd. (Subject)
| Form SC 13G/A | |
02/07/2024
8:38 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024
7:48 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024
7:49 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023
4:01 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023
4:03 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/21/2023
7:45 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
